Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
California NanotechnologiesTSXV:CNO -2.86%41 EBITDA Margin % is 20.68% as of Feb. 2026, which is 41% above its 10-year median of 14.70. GuruFocus rates TSXV:CNO with a GF Score™ of 41/100 and a GF Value™ of C$0.30 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,578 Chemicals companies, California Nanotechnologies ranks worse than 95.18% on this metric.
California Nanotechnologies (TSXV:CNO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
California Nanotechnologies EBITDA Margin % Related Terms
California Nanotechnologies EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:CNO vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, California Nanotechnologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
California Nanotechnologies EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, California Nanotechnologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where California Nanotechnologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies (TSXV:CNO) has a EBITDA Margin % of 20.68% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on California Nanotechnologies and its competitors. This is 41% above median its historical median of 14.70. According to the industry distribution chart, California Nanotechnologies ranks #1502 out of 1578 companies in the Chemicals industry, placing it in the top 95.2%.
Is California Nanotechnologies' EBITDA Margin % too high?
California Nanotechnologies' current EBITDA Margin % of 20.68% is 41% above median its 10-year median of 14.70. The Chemicals industry median EBITDA Margin % is 9.64. California Nanotechnologies' value of 20.68% is 114.5% above this industry median. Based on the distribution chart, California Nanotechnologies ranks #1502 out of 1578 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, California Nanotechnologies has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #1502 out of 1578 companies for EBITDA Margin %. This places California Nanotechnologies in the lower half of its industry. The industry median EBITDA Margin % is 9.64. California Nanotechnologies' value of 20.68% is 114.5% above this benchmark. While the company's 10-year median is 14.70 vs. the industry median of 9.64, California Nanotechnologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. California Nanotechnologies's current EBITDA Margin % of 20.68% is 114.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on California Nanotechnologies and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. California Nanotechnologies's current EBITDA Margin % is 20.68%, which is 41% above median its own 10-year median of 14.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (TSXV:CNO) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.30, compared to a current price of C$0.34 — trading 13.3% above its estimated fair value. The current EBITDA Margin % is 20.68%, which is 41% above median its 10-year median of 14.70 and 114.5% above the Chemicals industry median of 9.64. California Nanotechnologies' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For California Nanotechnologies (TSXV:CNO), the current EBITDA Margin % is 20.68% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is California Nanotechnologies (TSXV:CNO) Overvalued in 2026?
Based on GuruFocus' analysis, California Nanotechnologies stock appears to be overvalued.
The current stock price of C$0.34 is trading 13.3% above its estimated GF Value™ of C$0.30.
GuruFocus considers California Nanotechnologies to be Modestly Overvalued.
Key valuation signals for TSXV:CNO:
EBITDA Margin %: 20.68% (41% above median its 10-year median of 14.70)
GF Value™: C$0.30 vs. price of C$0.34 (13.3% above fair value)
Industry Position: 114.5% above the Chemicals median (#1502 of 1578)
No single metric tells the full story. See the TSXV:CNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
41GF Score
Get the complete analysis for TSXV:CNO
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CNO has been successfully added to your 
